Oxford Biomedica Solutions
Revanth Vankayalapati is a Senior Quality Assurance Specialist at Wave Life Sciences since October 2023, with extensive experience in the biopharmaceutical sector. Prior roles include Senior Specialist in Quality Assurance Operations at Oxford Biomedica Solutions, and Senior Quality Assurance Specialist at SQZ Biotechnologies. Revanth has demonstrated expertise in providing quality assurance support during manufacturing processes, reviewing batch records, and maintaining document control systems at companies such as Homology Medicines, Spectrum Pharmaceuticals, and Thermo Fisher Scientific. With a Master's degree in Project Management from Northeastern University and a Bachelor's degree in Pharmacy from GITAM Deemed University, Revanth combines technical knowledge with project management skills to enhance quality systems and operational efficiency.
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.